Glaukos (GKOS) Income from Non-Controlling Interests (2014 - 2015)
Glaukos' (GKOS) quarterly Income from Non-Controlling Interests came in at -$584000.0 in Q2 2015, down 39.05% year-on-year from -$958125.0 in Q2 2014, and down 17.74% on a QoQ basis from -$496000.0 in Q1 2015.
Glaukos (GKOS) Income from Non-Controlling Interests (2014 - 2015) Analysis & Trends
Glaukos (GKOS) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$584000.0 in Q2 2015.
- On a quarterly basis, Income from Non-Controlling Interests fell 39.05% year-over-year to -$584000.0 in Q2 2015; TTM through Dec 2015 was -$1.1 million, a N/A change from a year earlier, with the FY2023 full-year figure at $4.3 million, down 0.85% from the prior year.
- Income from Non-Controlling Interests for Q2 2015 stood at -$584000.0, down from -$496000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for GKOS reached as high as -$420000.0 in Q2 2014 and fell as low as -$647000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Glaukos | 8.79 Bn | 8.68 Bn | 117.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | -584,000.00 |
| Mar 31, 2015 | -496,000.00 |
| Dec 31, 2014 | -647,000.00 |
| Sep 30, 2014 | -482,000.00 |
| Jun 30, 2014 | -420,000.00 |